[1]
“QUALITY OF LIFE ASSESSMENT IN MULTIPLE MYELOMA PATIENTS UNDERGOING DOSE-REDUCED TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATION”, Mediterr J Hematol Infect Dis, vol. 3, no. 1, p. e2011057, Nov. 2011, doi: 10.4084/mjhid.2011.057.